Longitudinal Early-onset Alzheimer's Disease Study Protocol

NCT03507257 · clinicaltrials.gov ↗

RECRUITING

Status

850

Enrollment

OTHER

Sponsor class

Conditions

Early Onset Alzheimer Disease
Alzheimer Disease
Mild Cognitive Impairment

Interventions

DRUG: Flortaucipir
DRUG: Florbetaben
DRUG: Fluorodeoxyglucose

Sponsor

Indiana University

Collaborators

Alzheimer's Therapeutic Research Institute
National Institute on Aging (NIA)
Alzheimer's Association